Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Total Liabilities (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Total Liabilities for 16 consecutive years, with $222.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 3.56% to $222.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $222.2 million, a 3.56% increase, with the full-year FY2025 number at $222.2 million, up 3.56% from a year prior.
  • Total Liabilities was $222.2 million for Q4 2025 at Lemaitre Vascular, up from $219.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $222.2 million in Q4 2025 to a low of $34.7 million in Q1 2022.
  • A 5-year average of $88.0 million and a median of $45.4 million in 2023 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: plummeted 59.81% in 2021, then skyrocketed 393.5% in 2025.
  • Lemaitre Vascular's Total Liabilities stood at $38.7 million in 2021, then grew by 9.38% to $42.3 million in 2022, then increased by 15.62% to $48.9 million in 2023, then skyrocketed by 338.9% to $214.5 million in 2024, then increased by 3.56% to $222.2 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Total Liabilities are $222.2 million (Q4 2025), $219.1 million (Q3 2025), and $214.9 million (Q2 2025).